WCMM Fellow Daniel Öhlund receives a 4-year Starting grant from VR

The Wallenberg Molecular Medicine Fellow Daniel Öhlund receives a 4-year Starting grant from Vetenskapsrådet (VR) for a project entitled "Tumörstromat som läkemedelsmål vid pankreascancer".